Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus
about
Medication review in hospitalised patients to reduce morbidity and mortalityInterventions for enhancing medication adherenceMedication review in hospitalised patients to reduce morbidity and mortalityInterventions for enhancing medication adherenceInvestigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-AnalysisEffect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus.Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trialsEffective interventions to improve medication adherence in Type 2 diabetes: a systematic reviewImproving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a modelDoes the presence of a pharmacist in primary care clinics improve diabetes medication adherence?Physicians' and patients' valuation of pharmaceutical care implementation in Poznan (Poland) community pharmacies.Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital.Health care consumers' perspectives on pharmacist integration into private general practitioner clinics in Malaysia: a qualitative study.Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge.Improving adherence to medication in adults with diabetes in the United Arab EmiratesPharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials.Patient-Centered Outcomes of Medication Adherence Interventions: Systematic Review and Meta-Analysis.Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: study protocol for a randomized controlled trial.Influence of Race, Ethnicity and Social Determinants of Health on Diabetes Outcomes.The predictors to medication adherence among adults with diabetes in the United Arab EmiratesCollaborative Cardiovascular Risk Reduction in Primary Care II (CCARP II): Implementation of a systematic case-finding process for patients with uncontrolled risk factors.A systematic review of the evidence for pharmacist care of patients with dyslipidemia.Medication Adherence With Diabetes Medication: A Systematic Review of the Literature.Impact of Pharmaceutical Care Interventions on Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis.The need for PGY2-trained clinical pharmacy specialists.Evaluation of a quality-of-life tool for dogs with diabetes mellitus.Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care.Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled studyPharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial.Community pharmacy services in the United Arab Emirates.Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.The role of the pharmacist in the management of type 2 diabetes: current insights and future directions.Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients.Efficacy of Pharmacist Based Diabetes Educational Interventions on Clinical Outcomes of Adults With Type 2 Diabetes Mellitus: A Network Meta-Analysis.Non-adherence to diet and exercise recommendations amongst patients with type 2 diabetes mellitus attending Extension II Clinic in Botswana.Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical TrialCost-Effectiveness of Reducing Glycaemic Episodes Through Community Pharmacy Management of Patients with Type 2 Diabetes MellitusEffect of pharmaceutical care interventions on glycemic control in patients with diabetes: a systematic review and meta-analysisPhysician-community pharmacist collaborative care in diabetes management: a pilot study
P2860
Q24186116-8946F5AA-3E06-47C8-B0BF-06FEEA068B82Q24187912-C4E2D93B-6E6F-4F0F-8F4E-E2D2F56710E2Q24200610-A032A6E7-5657-49D6-BA92-00F2C3E5822FQ24243296-72CF1830-E982-41D0-AA3B-E1E77998AF4FQ26766537-72B92AF8-D57A-4BAA-A084-CE32FDAB7959Q33673866-832C21BF-491C-4D2A-ADD9-DAD1083CFE05Q33927651-5872649C-2EBF-4086-B670-2F30B5B14844Q34149256-5543A79E-FC6D-4B5C-906A-D097D74A3C3DQ34297241-C3B9DEBE-C087-45FF-B067-1FD3BE0DBB0DQ34414949-974B8169-81E3-464B-BD7F-FA2A4AFF1AD0Q34475629-6FA6A35C-5EEA-4D8B-A8BF-AF700FCF94FAQ34800124-1E7D4936-A692-4634-A0E2-6FB2C803227BQ35152604-728106B6-5B10-4DF1-BC1A-DB6FA61F369EQ35212797-15131AF7-D767-41F5-B4DB-76C94CE6D087Q36053099-26D45C91-A439-4EC6-BFE4-A2CBBD5F17CAQ36110531-DE809E09-0E28-47FC-84D7-A3670CA6A850Q36426692-A50FAA19-E33D-4773-94A6-0D97C3F8C32BQ36743058-1DED89A2-074F-452D-960F-DB06D5A7DE58Q36759847-EE048428-1B01-4803-B76F-396ED8F26E7BQ36807517-2921798A-7B50-42D9-9136-FA08F5EFA394Q37163615-45C73BB9-8C91-4158-8090-DF93EF943DE9Q37202535-83160831-D87E-4B0F-A8FC-501303C860C7Q37990847-F8D48828-AD7F-4A14-BC0E-B84CE7CA7E48Q38659210-B49C45BA-42A3-4640-A55B-56DC0615B6ABQ38882299-E968AEAF-9EB5-4CC3-946E-ADF1E18FA9CFQ39206096-C375FDDF-3367-40D7-8878-4F14D033F84AQ39610635-D3EE8D92-7820-49D0-933B-C9CACD4A1C74Q41902838-5C0E77DA-5CE7-4871-B1DB-335EBCBB4A0CQ42133031-8B1B0AA1-D1EF-4456-BC48-56E96EE10F84Q43445664-AE1CFA8E-ACF0-4D2A-AC44-9F4A29A6682BQ43743412-0E608EA7-EECB-4C7E-9078-B90892EB2532Q44566407-43BE0E4C-96AA-4E56-8072-EC188D8E43B6Q49385628-899479B5-E373-45F6-BC80-E6C04C68B0C9Q50521320-9B8DDD91-8B3A-4DBA-94DC-98E7A2A14659Q52564662-4DABC29B-89C1-48C1-9FA3-FEBD3ECDE1CCQ53817556-23B7C7B3-48CD-4252-8E77-EFB85F2B7CD9Q57165154-8F1F49C4-3F6A-4E2B-B0E3-4EA5DCE5E168Q57200162-64300E18-D4D7-4709-8CBF-98D24DB03A7FQ57490624-87C4DFC2-0336-4314-88F3-3ADF85968DF4Q58119629-F141AEDD-E451-4635-B752-9744D58C29EF
P2860
Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus
@en
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus.
@nl
type
label
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus
@en
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus.
@nl
prefLabel
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus
@en
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus.
@nl
P2093
P2860
P1476
Influence of pharmaceutical ca ...... with Type 2 diabetes mellitus
@en
P2093
James C McElnay
Mostafa Mohamed Kamal
Nadia Rashid Al Mazroui
Naserdeen Mehana Ghabash
Prashant Laxman Kole
Targ Ahmed Yacout
P2860
P304
P356
10.1111/J.1365-2125.2009.03391.X
P407
P577
2009-02-11T00:00:00Z